948
Y. Komatsu et al. / Bioorg. Med. Chem. 16 (2008) 941–949
dimethylformamide. The buffer composition was chan-
ged to 250 mM sodium phosphate (pH 8) or 100 mM so-
dium tetraborate (pH 8), and labeling reactions were
also carried out. The concentrations of the succinimidyl
ester groups (Cy3 and biotin) were 0.3 mM, and the
FITC labeling reactions were carried out at 5 mM. Ali-
quots were taken from the reaction solutions after 30
and 60 min, and were desalted with a cartridge column
(NAP5, Amersham Pharmacia). The products were ana-
lyzed by HPLC, using a reverse phase column and a
photodiode array detector (Waters). The percentages
of the products at each time point were determined from
the HPLC analysis.
(Supplementary data). QPCR was also carried out,
according to the standard method (Supplementary
data).
Acknowledgments
We thank Dr. Lim Chun Ren, Dr. Junya Hashida, and
Youji Ueda for their helpful discussions, and we thank
Naonori Inoue for technical assistance with the MAL-
DI-TOF/MS measurements. This work was carried
out with financial support from the National Institute
of Advanced Industrial Science and Technology
(AIST).
To study the effect of the carbonate ion on the coupling
reaction, 10 lM of the amino-modified ONT (Con-25,
ssN-25) was reacted with 0.3 mM biotin-NHS in the
presence of 250 mM sodium phosphate buffer (pH 8),
containing 0, 50, 100, 250 or 500 mM sodium carbonate
buffer (pH 8). The reactions were analyzed by the same
method as that used for the coupling reaction described
above.
Supplementary data
Supplementary data associated with this article can be
4.6. Computational simulation and pKa determination
See the Supplementary data.
References and notes
1. Maskos, U.; Southern, E. M. Nucleic Acids Res. 1992, 20,
1675.
2. Southern, E. M.; Case-Green, S. C.; Elder, J. K.; Johnson,
M.; Mir, K. U.; Wang, L.; Williams, J. C. Nucleic Acids
Res. 1994, 22, 1368.
3. Fodor, S. P.; Read, J. L.; Pirrung, M. C.; Stryer, L.; Lu, A.
T.; Solas, D. Science 1991, 251, 767.
4. Jacobs, J. W.; Fodor, S. P. Trends Biotechnol. 1994, 12, 19.
5. Egeland, R. D.; Marken, F.; Southern, E. M. Anal. Chem.
2002, 74, 1590.
6. Okamoto, T.; Suzuki, T.; Yamamoto, N. Nat. Biotechnol.
2000, 18, 438.
7. Beier, M.; Hoheisel, J. D. Nucleic Acids Res. 1999, 27,
1970.
8. Ramakrishnan, R.; Dorris, D.; Lublinsky, A.; Nguyen, A.;
Domanus, M.; Prokhorova, A.; Gieser, L.; Touma, E.;
Lockner, R.; Tata, M.; Zhu, X.; Patterson, M.; Shippy,
R.; Sendera, T. J.; Mazumder, A. Nucleic Acids Res. 2002,
30, e30.
4.7. Alkaline treatment of amino-modified ONTs
After the amino-modified ONTs (Con-T5, ssR-T5,
ssPro-T5; 50 nmol) were purified on the reverse phase
column, they were dissolved in concentrated aqueous
ammonia (3.3 mL), and heated at 60 °C. After 16 h,
the ammonia was removed under reduced pressure,
and then the residue was dissolved in distilled water
(1100 lL). The products (P1 and P2) were purified
by HPLC, and the molecular weights were determined
by MALDI-TOF/MS measurements (Supplementary
data). P1 and P2 were mixed with Con-T5 and the
starting material (ssR-T5, Con-T5 or ssPro-T5),
respectively, and the HPLC analysis using the reverse
phase column was carried out to compare the retention
times.
9. Taton, T. A.; Mirkin, C. A.; Letsinger, R. L. Science 2000,
289, 1757.
10. Elghanian, R.; Storhoff, J. J.; Mucic, R. C.; Letsinger, R.
L.; Mirkin, C. A. Science 1997, 277, 1078.
11. Pathak, S.; Choi, S. K.; Arnheim, N.; Thompson, M. E.
J. Am. Chem. Soc. 2001, 123, 4103.
12. Raddatz, S.; Mueller-Ibeler, J.; Kluge, J.; Wass, L.;
Burdinski, G.; Havens, J. R.; Onofrey, T. J.; Wang,
D.; Schweitzer, M. Nucleic Acids Res. 2002, 30,
4793.
13. Koch, T.; Jacobsen, N.; Fensholdt, J.; Boas, U.; Fenger,
M.; Jakobsen, M. H. Bioconjug. Chem. 2000, 11,
474.
14. Rehman, F. N.; Audeh, M.; Abrams, E. S.; Hammond, P.
W.; Kenney, M.; Boles, T. C. Nucleic Acids Res. 1999, 27,
649.
15. Epstein, J. R.; Lee, M.; Walt, D. R. Anal. Chem. 2002, 74,
1836.
16. Epstein, J. R.; Ferguson, J. A.; Lee, K. H.; Walt, D. R.
J. Am. Chem. Soc. 2003, 125, 13753.
17. Agrawal, S.; Christodoulou, C.; Gait, M. J. Nucleic Acids
Res. 1986, 14, 6227.
4.8. Microarray analyses of mRNAs collected from cell
lines
ssH-modified ONTs were designed and synthesized to
detect anti-sense RNAs (aRNAs) of PON2, LDHB,
APOH, IGFBPI, HBE1, GAPDH, and SSR4 (Supple-
mentary data). All ssH-modified ONTs were purified
with cartridge columns, according to our purification
protocol.
Microarrays were fabricated using a Prime Surface kitR
(BS-11607 Sumitomo Bakelite Co., Ltd.). The ssH-mod-
ified ONTs were dissolved in the spotting buffer to a
concentration of 10 lM, and then each ONT was depos-
ited in triplicate on the plastic plate with a spotting ma-
chine (MARKS-I, Hitachi Software Engineering, Co.,
Ltd.). Cy3 or Cy5 labeled anti-sense RNA (aRNA)
was prepared from HepG2 and K562 cells, and then
these aRNAs were subjected to microarray analyses